secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALATIN TECHNOLOGIES INC (PTN)
CIK:        0000911216
Form:       8-K
Filed at:   2023-05-01T23:59:59+00:00
Accession:  0001654954-23-005504
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Palatin to host KOL webinar on PL9643 Phase 3 dry eye data on May 8, 2023
-------------------------------------------------------------------------

- Webinar to review positive PL9643 Phase 3 MELODY-1 Lead-In population data for moderate to severe dry eye disease.
- Final PL9643 Phase 3 MELODY-1 data expected in H2 2023; trial enrollment continuing.
- Webinar moderated by CEO Carl Spana; featuring KOLs Dr. Stouch, Mr. Ousler, and CMO Dr. Raizman.
- Company cites PL9643 positive effects on both signs and symptoms of dry eye disease.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/911216/000165495423005504/0001654954-23-005504-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/911216/000165495423005504/ptn_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-005504

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer